SCHEMBL138697

SCHEMBL138697

COP(=O)(O)C(C)(C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
FDPS P14324 1/20 0.32
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10947345 0.80 DGAT1 (0.38) LMNAL3MBTL1
SCHEMBL138696 0.79 L3MBTL1 (0.32) ALDH1A1TSHRLMNAL3MBTL1CYP2C19
SCHEMBL3178600 0.79 ALDH1A1 (0.36) ALDH1A1TSHRLMNAL3MBTL1CYP2C19
SCHEMBL5707266 0.79 L3MBTL1 (0.32) ALDH1A1TSHRLMNAL3MBTL1CYP2C19
SCHEMBL7324253 0.78 LMNA (0.31) LMNA
SCHEMBL774999 0.77 ALDH1A1 (0.35) ALDH1A1TSHRLMNAFDPS
SCHEMBL5707267 0.77 ALDH1A1 (0.31) ALDH1A1TSHR
SCHEMBL9155595 0.75
SCHEMBL1336319 0.75 LMNA (0.45) ALDH1A1TSHRLMNAFDPSCYP2C19
SCHEMBL6579016 0.73 TSHR (0.40) ALDH1A1TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1035 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798105-A Preparation method of milabalin 长治医学院 2025-04-11 CN claimed
CN-116425671-A Synthesis method of 2-chloro-4- (trifluoromethyl) pyridine 江苏省农用激素工程技术研究中心有限公司 2023-07-14 CN claimed
CN-110627705-B N-benzyl indole thiosemicarbazone derivative, preparation and application 西北农林科技大学 2021-07-16 CN claimed
CN-111606836-B Preparation method of R-N-Boc-3-pyrrolidineacetic acid 上海馨远医药科技有限公司 2021-01-15 CN claimed
CN-111606836-A Preparation method of R-N-Boc-3-pyrrolidineacetic acid 上海馨远医药科技有限公司 2020-09-01 CN claimed
US-10723682-B2 Process for the synthesis of docosanol Biophone India Pharmaceuticals PVT, Ltd. (IN) 2020-07-28 US claimed
US-20190256459-A1 NOVEL PROCESS FOR THE PREPARATION OF BELINOSTAT BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2019-08-22 US claimed
CN-110139866-A It is used to prepare the intermediate of methanesulfonic acid eribulin and prepares its method 研成精密化学株式会社 2019-08-16 CN claimed
US-20190161425-A1 Novel Process for the Synthesis of Docosanol BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2019-05-30 US claimed
WO-2017199264-A1 NOVEL PROCESS FOR THE PREPARATION OF BELINOSTAT BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) 2017-11-23 WO claimed
EP-1791905-A1 MIXTURE, POLYESTER COMPOSITION, FILM AND METHOD FOR PRODUCING THE SAME Zimmer AG (DE) 2007-06-06 EP claimed
WO-2006034745-A1 MIXTURE, POLYESTER COMPOSITION, FILM AND METHOD FOR PRODUCING THE SAME ZIMMER AG (DE) 2006-04-06 WO claimed
US-20060069184-A1 Mixture, polyester composition, film and procedures for their manufacture ZIMMER AG (DE) 2006-03-30 US claimed
EP-1430065-B1 BETA-KETOPHOSPHONATES RHODIA CONS SPEC LTD (GB) 2005-02-02 EP claimed
EP-1264852-B1 Process for the preparation of polyester resins MONTEFIBRE SPA (IT) 2004-07-28 EP claimed
EP-1264852-A2 Process for the preparation of polyester resins Montefibre S.p.A. (IT) 2002-12-11 EP claimed
EP-1102736-A2 PREPARATION OF MACROCYCLIC KETONES UTILISING ADDITION OF KETONES TO ALKENES QUEST INTERNATIONAL B.V. (NL) 2001-05-30 EP claimed
WO-2000001648-A2 PREPARATION OF MACROCYCLIC KETONES UTILISING ADDITION OF KETONES TO ALKENES QUEST INTERNATIONAL B.V. (NL) 2000-01-13 WO claimed
US-5110930-A Herbicides AMERICAN CYANAMID COMPANY (US) 1992-05-05 US claimed
EP-0041623-B1 SUBSTITUTED IMIDAZOLINYL NICOTINE ACIDS, ESTERS AND SALTS AND USE THEREOF AS HERBICIDAL AGENTS AMERICAN CYANAMID COMPANY (US) 1985-08-28 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10723682-B2 Process for the synthesis of docosanol SQLE, ALOX5, DHCR7 ALDH1A1 2742/4885TSHR 3188/4885LMNA 1928/4885
US-20190256459-A1 NOVEL PROCESS FOR THE PREPARATION OF BELINOSTAT ACR, AADAC, CDK11A ALDH1A1 1516/4885TSHR 4339/4885LMNA 881/4885
US-20190161425-A1 Novel Process for the Synthesis of Docosanol SQLE, ALOX5, GGPS1 ALDH1A1 3093/4885TSHR 3610/4885LMNA 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.